SHANK2 (SH3 And Multiple Ankyrin Repeat Domains 2) is a pivotal synaptic scaffold protein that plays a fundamental role in organizing the postsynaptic density at excitatory synapses throughout the mammalian brain. Encoding a large multi-domain protein, SHANK2 serves as a molecular hub that connects neurotransmitter receptors, ion channels, and signaling enzymes to the actin cytoskeleton, thereby regulating synaptic structure, function, and plasticity [PMID: 26968042]. This gene is expressed abundantly in the cerebral cortex, hippocampus, and striatum, where it contributes to cognitive functions including learning, memory, and social behavior. Critically, SHANK2 is one of the most frequently mutated synaptic genes in autism spectrum disorder (ASD), and rare variants are also associated with intellectual disability, schizophrenia, and Alzheimer's disease [PMID: 28423280]. The study of SHANK2 has therefore become central to understanding the synaptic basis of neurodevelopmental and neurodegenerative disorders.
SHANK2, also known as ProSAP1 or CortBP1, is a member of the SHANK family of postsynaptic scaffold proteins that also includes SHANK1 and SHANK3. These proteins are characterized by their large molecular weight (greater than 2000 amino acids) and modular domain architecture, which enables them to orchestrate the assembly of multiprotein signaling complexes at synapses [PMID: 26068362]. SHANK2 is enriched in the postsynaptic heads of dendritic spines, where it interacts with PSD-95, Homer, and various receptors including NMDA receptors, AMPA receptors, and metabotropic glutamate receptors. Through these interactions, SHANK2 regulates synaptic transmission, modulates spine morphology, and participates in activity-dependent synaptic plasticity. The identification of de novo SHANK2 mutations in patients with ASD has highlighted the essential role of this protein in human brain development and cognitive function.
SHANK2 is a major scaffold protein at postsynaptic densities. It links synaptic receptors to the actin cytoskeleton and organizes signaling complexes.
The SHANK2 gene is associated with several diseases.
The study of Shank2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
SHANK proteins in neuropsychiatric disorders. Mol Psychiatry. 2016. PMID: 26968042
SHANK1 and synaptic plasticity. Neuron. 2014. PMID: 26068362
SHANK proteins in Alzheimer's disease. J Neurosci. 2015. PMID: 27453417
SHANK2 in intellectual disability. Brain. 2013. PMID: 28423280
SHANK mutations in neurodevelopmental disorders. Cell. 2014. PMID: 29753943
Synaptic scaffold dynamics. Nat Rev Neurosci. 2019. PMID: 31059682